Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-24 @ 4:54 AM
Study NCT ID:
NCT04058158
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2019-08-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria
Sponsor:
Samsung Bioepis Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SB12-3003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None